Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L3RO
|
||||
Former ID |
DIB012699
|
||||
Drug Name |
TAS-119
|
||||
Indication | Late-stage solid tumors [ICD9: 140-199, 210-229; ICD10:C00-C75, C7A, C7B, D10-D36, D3A] | Phase 1 | [549555] | ||
Company |
Taiho oncology
|
||||
Target and Pathway | |||||
Target(s) | Aurora kinase A | Target Info | Inhibitor | [549967] | |
KEGG Pathway | Oocyte meiosis | ||||
Pathway Interaction Database | Aurora B signaling | ||||
Signaling by Aurora kinases | |||||
Integrin-linked kinase signaling | |||||
PLK1 signaling events | |||||
Aurora A signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.